英格兰第四次全国“尿中有血”癌症宣传活动的前瞻性评估。
A prospective evaluation of the fourth national Be Clear on Cancer 'Blood in Pee' campaign in England.
机构信息
Institute of Health Research, University of Exeter Medical School, University of Exeter, Exeter, UK.
NIHR ARC South West Peninsula (PenARC), University of Exeter Medical School, University of Exeter, Exeter, UK.
出版信息
Eur J Cancer Care (Engl). 2022 Sep;31(5):e13606. doi: 10.1111/ecc.13606. Epub 2022 May 15.
OBJECTIVE
To assess the impact of the fourth Be Clear on Cancer (BCoC) 'Blood in Pee' (BiP) campaign (July to September 2018) on bladder and kidney cancer symptom awareness and outcomes in England.
METHODS
In this uncontrolled before and after study, symptom awareness and reported barriers to GP attendance were assessed using panel and one-to-one interviews. The Health Improvement Network (THIN), National Cancer Registration and Analysis Service (NCRAS) and NHS Cancer Waiting Times (CWT) data were analysed to assess the impact on GP attendances, urgent cancer referrals, cancer diagnoses and 1-year survival. Analyses used Poisson, negative binomial and Cox regression.
RESULTS
Symptom awareness and intention to consult a GP after one episode of haematuria increased following the campaign. GP attendance with haematuria (rate ratio (RR) 1.17, 95% confidence interval (CI): 1.07-1.28) and urgent cancer referrals (RR 1.18 95% CI: 1.08-1.28) increased following the campaign. Early-stage diagnoses increased for bladder cancer (difference in percentage 2.8%, 95% CI: -0.2%-5.8%), but not for kidney cancer (difference -0.6%, 95% CI: -3.2%-2.1%).
CONCLUSIONS
The fourth BCoC BiP campaign appears to have been effective in increasing bladder cancer symptom awareness and GP attendances, although long-term impacts are unclear.
目的
评估第四次“Be Clear on Cancer”（BCoC）“血尿”（BiP）活动（2018 年 7 月至 9 月）对英格兰膀胱癌和肾癌症状意识和结局的影响。
方法
在这项无对照的前后研究中，使用小组和一对一访谈评估症状意识和报告的 GP 就诊障碍。分析了健康改善网络（THIN）、国家癌症登记和分析服务（NCRAS）和 NHS 癌症等待时间（CWT）数据，以评估对 GP 就诊、紧急癌症转诊、癌症诊断和 1 年生存率的影响。分析使用泊松、负二项和 Cox 回归。
结果
在活动之后，单次血尿后出现症状意识和咨询 GP 的意愿增加。出现血尿后 GP 就诊（比率比（RR）1.17，95%置信区间（CI）：1.07-1.28）和紧急癌症转诊（RR 1.18 95% CI：1.08-1.28）增加。膀胱癌的早期诊断增加（差异百分比为 2.8%，95% CI：-0.2%-5.8%），但肾癌无增加（差异-0.6%，95% CI：-3.2%-2.1%）。
结论
第四次 BCoC BiP 活动似乎有效地提高了膀胱癌症状意识和 GP 就诊率，尽管长期影响尚不清楚。
Zotero 插件